What is Natera?
Natera is at the forefront of personalized genetic testing and diagnostics, with a primary focus on oncology, women's health, and organ health. The company's mission is to integrate cfDNA testing into standard medical practice, thereby enabling earlier and more targeted interventions to promote longer, healthier lives. Their innovative approach aims to revolutionize patient care through precise genetic insights.
How much funding has Natera raised?
Natera has raised a total of $1B across 12 funding rounds:
Grant
$2M
Series D
$20M
Series E
$54.6M
Series F
$55.5M
Stock Offering
$180M
Stock Offering
$90M
Stock Offering
$100M
Stock Offering
$200M
Debt
$287.5M
Grant (2011): $2M featuring National Institutes of Health
Series D (2012): $20M backed by Lightspeed Venture Partners, Claremont Creek Ventures, and Steamboat Ventures
Series E (2013): $54.6M with participation from Steamboat Ventures, Claremont Creek Ventures, Founders Fund, Lightspeed Venture Partners, OrbiMed, and Harmony Group Capital
Series F (2015): $55.5M led by Steamboat Ventures, OrbiMed, RA Capital Management, Franklin Templeton Investments, HealthCor Partners, Jennison Associates, Capital Research and Management, and Sofinnova Ventures
Stock Issuance/Offering (2015): $180M, investors not publicly disclosed
Stock Issuance/Offering (2018): $90M, investors not publicly disclosed
Stock Issuance/Offering (2019): $100M, investors not publicly disclosed
Stock Issuance/Offering (2019): $200M, investors not publicly disclosed
Debt (2020): $287.5M, investors not publicly disclosed
Key Investors in Natera
Steamboat Ventures
Steamboat Ventures is a venture capital firm focused on helping young companies become market leaders. They invest in early to growth-stage companies within technology, media, and consumer sectors, dedicated to creating lasting value.
Claremont Creek Ventures
Claremont Creek Ventures is a seed and early-stage venture firm specializing in IT-driven opportunities, particularly in digital healthcare, energy technology, and online businesses. They focus on building successful companies through efficient capital use and strong teams.
OrbiMed
OrbiMed is a specialized investment firm focused on the healthcare sector, managing capital across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services. They support companies at various development stages with deep industry expertise.
What's next for Natera?
The substantial enterprise-level capital infusion, including the recent strategic investment, positions Natera for accelerated growth and further innovation. This financing is expected to fuel advancements in their diagnostic platforms, expand their market reach, and support ongoing research and development efforts. Natera's strategic focus on integrating advanced genetic testing into mainstream healthcare suggests a trajectory towards becoming an indispensable tool in disease management and preventative care.
See full Natera company page
